Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
Max Kam‐Kwan Chan, Emily Lok-Yiu Chan, Zoey Zeyuan Ji, Alex Siu Wing Chan, Chunjie Li, Kam Tong Leung, Ka‐Fai To, Patrick Ming‐Kuen Tang
Abstract
Transforming growth factor-β (TGF-β) signaling is an important pathway for promoting the pathogenesis of inflammatory diseases, including cancer. The roles of TGF-β signaling are heterogeneous and versatile in cancer development and progression, both anticancer and protumoral actions are reported. Interestingly, increasing evidence suggests that TGF-β enhances disease progression and drug resistance via immune-modulatory actions in the tumor microenvironment (TME) of solid tumors. A better understanding of its regulatory mechanisms in the TME at the molecular level can facilitate the development of precision medicine to block the protumoral actions of TGF-β in the TME. Here, the latest information about the regulatory mechanisms and translational research of TGF-β signaling in the TME for therapeutic development had been summarized.